BDBM38805 (2E)-2-cyano-2-[5-(2-hydroxyethyl)-4-oxidanylidene-3-phenyl-1,3-thiazolidin-2-ylidene]-N-(phenylmethyl)ethanamide::(2E)-2-cyano-2-[5-(2-hydroxyethyl)-4-oxo-3-phenyl-2-thiazolidinylidene]-N-(phenylmethyl)acetamide::(2E)-N-benzyl-2-cyano-2-[5-(2-hydroxyethyl)-4-keto-3-phenyl-thiazolidin-2-ylidene]acetamide::(2E)-N-benzyl-2-cyano-2-[5-(2-hydroxyethyl)-4-oxo-3-phenyl-1,3-thiazolidin-2-ylidene]acetamide::MLS000077517::SMR000042286::cid_661795
SMILES OCCC1S\C(N(C1=O)c1ccccc1)=C(/C#N)C(=O)NCc1ccccc1
InChI Key InChIKey=VOYIKNKCDBBBND-HEHNFIMWSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 38805
TargetM-phase inducer phosphatase 2(Homo sapiens (Human))
University of Pittsburgh
Curated by PubChem BioAssay
University of Pittsburgh
Curated by PubChem BioAssay
Affinity DataIC50: >5.00E+4nMAssay Description:The Cdc25B Phosphatase HTS dose response confirmation has been developed to confirm actives identified in the Cdc25B HTS AID 368, screened at the Uni...More data for this Ligand-Target Pair